RNA-Seq – News and Features

Collaboration to create facility for proteomics profiling of RNAi and drug effects in human cells.

Molecules targeted at various cancers, inflammatory diseases and cardio-vascular indications.

All three institutions will rely on Agilent’s genomics solution, comprising microarrays, reagents, hardware and data analysis tools.

DYN G.S. is aiming to become a specialized center for providing sequencing services.

Research and Markets announces the addition of "The Future of Metabolomics: Building Competitive Advantage in Drug Discovery, Clinical Development and Diagnostics"

Max Planck will use Roche’s Genome Sequencer 20 system to produce a draft genome sequence for the Bonobo or Pygmy Chimpanzee.

The agreement gives Center for Nurtigenomics full access to the Genomatix Microarray Analysis Pipeline.

Genedata has developed a computational system to analyze molecular processes in mammalian liver cells.

Company will provide research informatics for the consortium’s efforts to improve cancer diagnosis and treatment.

Research involves sequencing, genome-wide functional studies and strain and process design.